News & insights

Exploring Innovation in Alzheimer’s Disease Research Highlights from CTAD 2024 17th Clinical Trials on Alzheimer’s Disease (CTAD) Madrid (Spain) October 29 – November 1, 2024 Last week, our team travelled to Madrid to participate in the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference, where we had the opportunity to...

CTAD24 | Posters & Content Madrid, Spain | 29 October – 1 November 2024 This week, our team traveled to Madrid to attend CTAD 2024, where they presented several posters and hosted a session on Validating Speech-Based Biomarkers for Measuring Disease Progression in Alzheimer’s Disease (AD). These materials are now...

Highlights from the Clinical Trials Innovation Summit 2024 San Francisco, CA – 22nd October 2024 The 2024 Clinical Trials Innovation Summit, hosted by Genentech in San Francisco, gathered experts from across the clinical trial field to reimagine patient care through AI-driven innovation. Featuring industry leaders, clinicians, and researchers this event...

CTAD24 | Clinical Trials on Alzheimer’s Disease Madrid, Spain | 29 October – 1 November 2024 Be the first to gain access to new data and insights, presented at CTAD24. Access Posters This year at CTAD, we can’t wait to share our latest research with you. There will be four...

Revolutionizing Clinical Trial Central Monitoring: Automated Quality Assurance for Faster, Scalable Monitoring by Rachel Newsome, PhD Tuesday 22nd October at 15:45  Accurate administration of rater-based clinical instruments, such as the Clinical Dementia Rating (CDR), is critical for reliable clinical outcomes in Alzheimer’s Disease (AD) trials. However, existing gold-standard quality assurance...